Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2023 Financial Results on February 6, 2024
09 Enero 2024 - 7:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release
financial results for the fourth quarter and fiscal 2023 after the
close of trading on Tuesday, February 6. Inspire’s management team
will host a corresponding conference call beginning at 5:00 p.m.
Eastern Time to discuss the financial results and recent business
developments.
A webcast of the call will be accessible via the Investor
Relations page of the Inspire website or through this link:
Inspire's Q4 2023 earnings call webcast. For those not planning to
ask a question of management, the Company recommends listening via
the webcast.
If you plan to ask a question, please use the following
link: Inspire's Q4 2023 earnings call. After registering, an
email will be sent, including dial-in details and a unique
conference call access code required to join the live call. To
ensure you are connected prior to the beginning of the call, the
Company suggests registering a minimum of 10 minutes before the
start of the call.
Following the call, a replay will be available on the Company's
Investor Relations website approximately two hours after the event
and archived on the site for two weeks.
About Inspire Medical SystemsInspire is a
medical technology company focused on the development and
commercialization of innovative, minimally invasive solutions for
patients with obstructive sleep apnea. Inspire’s proprietary
Inspire therapy is the first and only FDA-approved neurostimulation
technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice
President, Investor Relationsezgiyagci@inspiresleep.com
617-549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Inspire Medical Systems (NYSE:INSP)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024